Systematic Review: Charged-Particle Radiation Therapy for Cancer
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Radiation therapy with charged particles can potentially deliver maximum doses while minimizing irradiation of surrounding tissues, and it may be more effective or less harmful than other forms of radiation therapy. PURPOSE: To review evidence about the benefits and harms of charged-particle radiation therapy for patients with cancer. DATA SOURCES: MEDLINE (inception to 11 July 2009) was searched for publications in English, German, French, Italian, and Japanese. Web sites of manufacturers, treatment centers, and professional organizations were searched for relevant information. STUDY SELECTION: Four reviewers identified studies of any design that described clinical outcomes or adverse events in 10 or more patients with cancer treated with charged-particle radiation therapy. DATA EXTRACTION: The 4 reviewers extracted study, patient, and treatment characteristics; clinical outcomes; and adverse events for nonoverlapping sets of articles. A fifth reviewer verified data on comparative studies. DATA SYNTHESIS: Currently, 7 centers in the United States have facilities for particle (proton)-beam irradiation, and at least 4 are under construction, each costing between $100 and $225 million. In 243 eligible articles, charged-particle radiation therapy was used alone or in combination with other interventions for common (for example, lung, prostate, or breast) or uncommon (for example, skull-base tumors or uveal melanomas) types of cancer. Of 243 articles, 185 were single-group retrospective studies. Eight randomized and 9 nonrandomized clinical trials compared treatments with or without charged particles. No comparative study reported statistically significant or important differences in overall or cancer-specific survival or in total serious adverse events. LIMITATION: Few studies directly compared treatments with or without particle irradiation. CONCLUSION: Evidence on the comparative effectiveness and safety of charged-particle radiation therapy in cancer is needed to assess the benefits, risks, and costs of treatment alternatives.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Equipoise and the Ethics of Clinical Research
Freedman, B. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707163170304 · Cited by 2,339 · cited 1×
“In reality, it is very likely that there are many instances of clinical equipoise (63) between charged-particle radiation therapy and other modalities, for both common and rare types of cancer.”
Zietman, A. L., DeSilvio, M. L., Slater, J. D., Rossi, C. J., Miller, D. W., Adams, J. A., & Shipley, W. U. (2005) · JAMA · doi:10.1001/jama.294.10.1233 · Cited by 1,224 · cited 2×
“…Brain glioblastoma United States, 1989–1992 To examine whether an escalated dose could improve local control without excess brain injury Local control No ND Zietman et al, 2005 (42) Prostate cancer United States, 1996–1999 To examine whether an increased dose improves tumor control compared with…”
Research works printed but not linked: 55
- 10.3322/CA.2007.0010 · DOI · Paper page
- 10.1200/JCO.2008.17.1843 · doi:10.1200/jco.2008.17.1843
- 10.1038/sj.bjc.6602754 · DOI · Paper page
- 10.1016/S1470-2045(08)70098-6 · DOI · Paper page
- 10.1016/j.ijrobp.2003.09.041 · DOI
- 10.1118/1.1350587 · doi:10.1118/1.1350587
- 10.1200/JCO.2006.09.7816 · DOI · Paper page
- 10.1016/S1470-2045(06)70795-1 · DOI
- 10.1001/jama.297.24.2705 · DOI · Paper page
- 10.1080/02841860500361049 · doi:10.1080/02841860500361049
- 10.1053/clon.2002.0174 · doi:10.1053/clon.2002.0174
- 10.1080/02841860500341157 · DOI · Paper page
- 10.1200/JCO.2006.09.0811 · DOI
- 10.1016/j.radonc.2008.07.015 · DOI
- Chui G, 2008, Symmetry, 5, 24
- 10.1002/cncr.21284 · doi:10.1002/cncr.21284
- 10.1200/JCO.2006.09.7469 · DOI · Paper page
- 10.1016/j.hoc.2006.01.008 · doi:10.1016/j.hoc.2006.01.008
- 10.1007/BF02303815 · doi:10.1007/bf02303815
- 10.1016/S0167-8140(01)00495-9 · doi:10.1016/s0167-8140(01)00495-9
- 10.1200/JCO.2006.10.0255 · doi:10.1200/jco.2006.10.0255
- 10.1245/s10434-008-0287-2 · DOI
- Herrmann T, 1987, Radiobiol Radiother (Berl), 28, 519
- 10.1016/0167-8140(95)97447-L · doi:10.1016/0167-8140(95)97447-l
- 10.1016/0167-8140(95)97448-M · DOI · Paper page
- 10.1016/S0161-6420(89)32648-0 · doi:10.1016/s0161-6420(89)32648-0
- 10.1016/S0161-6420(93)31446-6 · doi:10.1016/s0161-6420(93)31446-6
- 10.1148/radiology.168.1.3132732 · doi:10.1148/radiology.168.1.3132732
- 10.1016/0360-3016(95)00063-5 · DOI · Paper page
- 10.1016/0360-3016(93)90978-5 · doi:10.1016/0360-3016(93)90978-5
- 10.1001/archopht.118.6.773 · DOI · Paper page
- 10.1016/S0360-3016(98)00031-5 · DOI
- 10.1016/S0360-3016(97)00039-4 · doi:10.1016/s0360-3016(97)00039-4
- 10.1159/000094834 · doi:10.1159/000094834
- Desjardins L, 2003, J Fr Ophtalmol, 26, 269
- 10.1016/S0161-6420(90)32512-5 · doi:10.1016/s0161-6420(90)32512-5
- 10.1016/0002-9394(85)90357-5 · DOI
- 10.1136/bjo.80.2.117 · doi:10.1136/bjo.80.2.117
- 10.1016/S0161-6420(99)90456-6 · doi:10.1016/s0161-6420(99)90456-6
- 10.1016/S0002-9394(02)02292-4 · doi:10.1016/s0002-9394(02)02292-4
- 10.1002/cncr.21158 · doi:10.1002/cncr.21158
- 10.1016/0360-3016(93)90423-S · doi:10.1016/0360-3016(93)90423-s
- 10.1097/00000658-199403000-00006 · doi:10.1097/00000658-199403000-00006
- 10.1158/1078-0432.CCR-05-1907 · DOI
- Galbraith ME, 2001, Oncol Nurs Forum, 28, 551
- 10.1002/1097-0142(19830501)51:9<1599::AID-CNCR2820510908>3.0.CO;2-O · doi:10.1002/1097-0142(19830501)51:9<1599::aid-cncr2820510908>3.0.co;2-o
- 10.1200/JCO.2006.10.0131 · DOI · Paper page
- 10.1016/j.radonc.2007.03.001 · DOI · Paper page
- 10.1016/j.radonc.2007.04.007 · DOI
- 10.1200/JCO.2007.14.4329 · doi:10.1200/jco.2007.14.4329
- 10.1016/j.radonc.2007.12.024 · DOI
- 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B · doi:10.1002/(sici)1097-0258(19981015)17:19<2265::aid-sim918>3.0.co;2-b
- 10.1001/jama.297.3.278 · DOI · Paper page
- 10.1136/bmj.39070.527986.68 · DOI · Paper page
- 10.1177/107327480701400209 · DOI
Cited by
Newhauser, W. D., & Zhang, R. (2015) · Physics in Medicine and Biology · doi:10.1088/0031-9155/60/8/r155 · Cited by 675
Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience
Kamada, T., Tsujii, H., Blakely, E. A., Debus, J., De Neve, W., Durante, M., Jäkel, O., Mayer, R., Orecchia, R., Pötter, R., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70412-7 · Cited by 562
Selection of Appropriate Wound Dressing for Various Wounds
Shi, C., Wang, C., Liu, H., Li, Q., Li, R., Zhang, Y., Liu, Y., Shao, Y., & Wang, J. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00182 · Cited by 522
“It is used to treat cancer that is not suitable for surgery or assist surgery (Terasawa et al., 2009).”
BackgroundMechanisms and Consequences of Double‐Strand DNA Break Formation in Chromatin
Cannan, W. J., & Pederson, D. S. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25048 · Cited by 499
Goldin, G. H. (2012) · JAMA · doi:10.1001/jama.2012.460 · Cited by 445
Metadata
- Authors
- Terasawa, T., Dvorak, T., Ip, S., Raman, G., Lau, J., & Trikalinos, T. A.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2009-10-20
- Volume
- 151
- Issue
- 8
- Pages
- 556-565
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2054729949
- Cited by
- 104
- References
- 2
- FWCI
- 1.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Systematic Review: Charged-Particle Radiation Therapy for Cancer. https://app.cochat.ai/papers/10.7326/0003-4819-151-8-200910200-00145
- The paper
- Terasawa, T., Dvorak, T., Ip, S., Raman, G., Lau, J., & Trikalinos, T. A. (2009). Systematic Review: Charged-Particle Radiation Therapy for Cancer. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-151-8-200910200-00145
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.